{"nct_id":"NCT05130866","title":"Efficacy and Safety of REC-2282 in Patients With Progressive Neurofibromatosis Type 2 (NF2) Mutated Meningiomas","status":"TERMINATED","status_verified_date":"2025-10","start_date":"2022-06-20","start_date_type":"ACTUAL","primary_completion_date":"2025-08-18","primary_completion_date_type":"ACTUAL","completion_date":"2025-08-18","completion_date_type":"ACTUAL","phases":["PHASE2","PHASE3"],"tickers":["RXRX"]}